Trends in Medication Choices for Hypertension in the Elderly

Slides:

Advertisements

Similar presentations

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium.

Advertisements

JNC 8 Guidelines….

The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure

Stanford Prevention Research Center STANFORD SCHOOL OF MEDICINE National Trends in the Prescribing of Anti-Hypertensive Medications Jun Ma, MD, PhD Research.

Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP

Drugs for Hypertension

Hypertension JNC VII classification * * The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High.

TRANSLATING VISITS INTO PATIENTS USING AMBULATORY VISIT DATA (Hypertensive patient case study) by Esther Hing, M.P.H. and Julia Holmes, Ph.D U.S. DEPARTMENT.

IMPACT OF AN ESSENTIAL DRUGS LIST AND TREATMENT GUIDELINES ON PRESCRIBING IN SOUTH AFRICA In 1998 the National Department of Health (NDOH) published standard.

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 46 Vasodilators.

JNC 7 血壓分期. 血壓分期 JNC 7 ： 1. 增加高血壓前期 2.Stages 2 及 3 高血壓被合併 JNC 7, 2003.

Therapeutics Conference. Fluid Resuscitation Early correction of fluid deficit is essential in hypovolemic shock to prevent decline in tissue perfusion.

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Renoprotective Effect of Renin-Angiotensin-Aldosterone.

Date of download: 6/28/2016 From: Drug Treatment of Hypertension in the Elderly: A Meta-Analysis Ann Intern Med. 1994;121(5): doi: /

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/AHA 2011 Expert Consensus Document on Hypertension.

JNC VIII Hypertension.

Health April 13, 2017.

Hypertension JNC VIII Guidelines.

Copyright © 2015 American Medical Association. All rights reserved.

Copyright © 2005 American Medical Association. All rights reserved.

Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.

Drugs for Hypertension

Evidence-based treatment algorithm, including clinical trials published through A, B, and C are levels of evidence defined as follows—Level of Evidence:

Copyright © 2013 American Medical Association. All rights reserved.

by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B

Copyright © 2002 American Medical Association. All rights reserved.

Diagram representing the renin–angiotensin–aldosterone system

Algorithm for guideline-directed medical therapy for patients with SIHD. Colors correspond to the class of recommendations in the ACCF/AHATable The.

Subclinical organ damage Treatment LVH

Isolated Systolic Hypertension: An Update After SPRINT

Evaluation of Left Ventricular Enlargement as a Marker of Early Disease in Familial Dilated CardiomyopathyClinical Perspective by Diane Fatkin, Thomas.

Behavior and Biology: The Basic Sciences for AHA Action

Ahead of the Curve by Alun D. Hughes Hypertension Volume 64(5):

Pulse Pressure and Resistance Artery Structure in the Elderly

Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.

UNIT 2: ANTIHYPERTENSIVE DRUGS

Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy: Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene? Sumeet Gupta, MPharm, PhD,

Nat. Rev. Nephrol. doi: /nrneph

Thinking Beyond New Clinical Guidelines: Update in Hypertension

Step Care Therapy for Hypertension in Diabetic Patients

Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,

Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus George L. Bakris, MD Mayo Clinic.

Background for understanding the Hypertension literature.

Chapter 21: Drugs for Hypertension

Category Hypertension Normal < 130/< 85 Recheck in 2 years. High Normal 130–139/ 85–89 Recheck in 1 year Hypertension Stage 1 (mild) 140–159/90–99.

Fig. 2. Evidence-based medication prescriptions

Table of Contents Why Do We Treat Hypertension? Recommendation 5

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Choice of the study design (superiority vs non-inferiority design) for postregistration trials comparing different treatments for the same therapeutic.

Primary Hypertension Max C. Reif, M.D.

Hypertension After Kidney Transplant

Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension A. Davenport, C. Cox, R. Thuraisingham Kidney.

Chapter 32 Assessment and Management of Patients With Hypertension

Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect? Areef Ishani, Charles A. Herzog,

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

Managing Blood Pressure

Volume 67, Pages S52-S54 (January 2005)

Adjunctive Therapies in the Treatment of Acute Coronary Syndromes

Isolated Systolic Hypertension: An Update After SPRINT

M. A. Levin, G. W. Fischer, H. -M. Lin, P. J. McCormick, M. Krol, D. L

KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

(A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels. (A) Distribution of CsA nephrotoxicity lesions.

Unadjusted odds ratio of death at 6 mo for medications (β blockers [BBL], angiotensin-converting enzyme inhibitors [ACEI]/angiotensin receptor blockers.

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

Schematic of the interaction between the renin-angiotensin-aldosterone system (RAAS) system and the natriuretic peptides and how the RAAS modulators and.

Fig. 3: Possible algorithm for controlling blood pressure in diabetic patients with microalbuminuria. [This algorithm is based on the opinions and practice.

Hypertension & Exercise 杨晓冬级临床医学（八年制）

Copyright Notice You are authorized to use these slides subject to the following terms, conditions and exceptions: They are to be used solely for personal,

Presentation transcript:

Trends in Medication Choices for Hypertension in the Elderly by Mark Monane, Robert J. Glynn, Jerry H. Gurwitz, Rhonda L. Bohn, Raisa Levin, and Jerry Avorn Hypertension Volume 25(5):1045-1051 May 1, 1995 Copyright © American Heart Association, Inc. All rights reserved.

Graph shows frequency distribution of new prescriptions for antihypertensive agents by class for each year over the study interval 1982 through 1988. Graph shows frequency distribution of new prescriptions for antihypertensive agents by class for each year over the study interval 1982 through 1988. CCBs indicates calcium channel blockers; B-BLOCKERS, β-adrenergic blockers; ACE INHIB, angiotensin-converting enzyme inhibitors; PERIPH ANTAG, peripheral adrenergic antagonists; and VASODIL, vasodilators. Mark Monane et al. Hypertension. 1995;25:1045-1051 Copyright © American Heart Association, Inc. All rights reserved.

Graph shows proportion of new antihypertensive prescriptions for diuretics by year in relation to the publication of peer-reviewed articles in the literature. Graph shows proportion of new antihypertensive prescriptions for diuretics by year in relation to the publication of peer-reviewed articles in the literature. Studies presented to the left of the graph were published before the 1982 to 1988 interval examined in the present article. Abbreviations to the left: VA indicates Veterans Administration Cooperative Study Group on Antihypertensive Agents (1967)30 ; JNC I, Joint National Committee Report on Detection, Evaluation, and Treatment of High Blood Pressure (1977)4 ; USPHS, US Public Health Service Hospitals Cooperative Study Group (1977)31 ; HDFP, Hypertension Detection and Follow-up Program Cooperative Group (1979)32 ; JNC II, Joint National Committee Report on Detection, Evaluation, and Treatment of High Blood Pressure (1980)5 ; OSLO, Oslo Study (1980)33 ; and AUST, Australian Therapeutic Trial in Mild Hypertension (1981).34 Abbreviations within the graph: HDFP indicates Hypertension Detection and Follow-up Program Cooperative Group (1982)35 ; VA, Veterans Administration Cooperative Study Group on Antihypertensive Agents (1982)36 ; JNC III, Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1984)6 ; EWPHE, European Working Party on High Blood Pressure in the Elderly Trial (1985)37 ; MRC, Medical Research Council Working Party (1985)38 ; WG, Working Group on Hypertension in the Elderly (1986)39 ; COOPE, Coope and Warrender (1986)40 ; WIKSTRAND, Wikstrand et al (1986)41 ; and JNC IV, Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1988).7 Mark Monane et al. Hypertension. 1995;25:1045-1051 Copyright © American Heart Association, Inc. All rights reserved.